These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 33306486)

  • 1. Choice of biologics in asthma endotypes.
    Wangberg H; Woessner K
    Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):79-85. PubMed ID: 33306486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic and New Therapies in Asthma.
    Tabatabaian F; Ledford DK; Casale TB
    Immunol Allergy Clin North Am; 2017 May; 37(2):329-343. PubMed ID: 28366480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of asthma endotypes: implications for therapy.
    Stokes JR; Casale TB
    Ann Allergy Asthma Immunol; 2016 Aug; 117(2):121-5. PubMed ID: 27499539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pragmatic Clinical Perspective on Biologics for Severe Refractory Type 2 Asthma.
    Chan R; RuiWen Kuo C; Lipworth B
    J Allergy Clin Immunol Pract; 2020; 8(10):3363-3370. PubMed ID: 32673880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Biologics in Severe Asthma.
    Pavord ID; Hilvering B; Shrimanker R
    Immunol Allergy Clin North Am; 2016 Aug; 36(3):609-23. PubMed ID: 27401629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New perspectives of biological therapy for severe asthma in adults and adolescents.
    Chheang C; Guinand S; von Garnier C; Sartori C
    Swiss Med Wkly; 2022 May; 152():w30176. PubMed ID: 35748315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe asthma: what is new in the new millennium.
    Ntontsi P; Samitas K; Zervas E; Gaga M
    Curr Opin Allergy Clin Immunol; 2020 Apr; 20(2):202-207. PubMed ID: 32004177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Current State of Biologic Therapies for Treatment of Refractory Asthma.
    Mavissakalian M; Brady S
    Clin Rev Allergy Immunol; 2020 Oct; 59(2):195-207. PubMed ID: 31981048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologics for the Treatments of Allergic Conditions: Severe Asthma.
    Caminati M; Bagnasco D; Rosenwasser LJ; Vianello A; Senna G
    Immunol Allergy Clin North Am; 2020 Nov; 40(4):549-564. PubMed ID: 33012319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Targets for Biological Therapies of Severe Asthma.
    Pelaia C; Crimi C; Vatrella A; Tinello C; Terracciano R; Pelaia G
    Front Immunol; 2020; 11():603312. PubMed ID: 33329598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of T2 inflammation biomarkers in severe asthma.
    Parulekar AD; Diamant Z; Hanania NA
    Curr Opin Pulm Med; 2016 Jan; 22(1):59-68. PubMed ID: 26574724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancements in biologic therapy in eosinophilic asthma.
    Patadia R; Casale TB; Fowler J; Patel S; Cardet JC
    Expert Opin Biol Ther; 2024 Apr; 24(4):251-261. PubMed ID: 38619468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Critical Evaluation of Anti-IL-13 and Anti-IL-4 Strategies in Severe Asthma.
    Bagnasco D; Ferrando M; Varricchi G; Passalacqua G; Canonica GW
    Int Arch Allergy Immunol; 2016; 170(2):122-31. PubMed ID: 27637004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to Assess Effectiveness of Biologics for Asthma and What Steps to Take When There Is Not Benefit.
    Pepper AN; Hanania NA; Humbert M; Casale TB
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1081-1088. PubMed ID: 33685606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asthma Phenotypes as a Guide for Current and Future Biologic Therapies.
    Hamilton D; Lehman H
    Clin Rev Allergy Immunol; 2020 Oct; 59(2):160-174. PubMed ID: 31359247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma.
    Katsaounou P; Buhl R; Brusselle G; Pfister P; Martínez R; Wahn U; Bousquet J
    Respir Med; 2019 Apr; 150():51-62. PubMed ID: 30961951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Emerging Role for Exhaled Nitric Oxide in Guiding Biological Treatment in Severe Asthma.
    Rolla G; Heffler E; Pizzimenti S; Michils A; Malinovschi A
    Curr Med Chem; 2020; 27(42):7159-7167. PubMed ID: 32660394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological treatments for severe asthma: A major advance in asthma care.
    Busse WW
    Allergol Int; 2019 Apr; 68(2):158-166. PubMed ID: 30792118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the interleukin-4 and interleukin-13 pathways in severe asthma: current knowledge and future needs.
    Parulekar AD; Kao CC; Diamant Z; Hanania NA
    Curr Opin Pulm Med; 2018 Jan; 24(1):50-55. PubMed ID: 29036019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precision care in the treatment of pediatric asthma.
    Mahmood L; Keskin S; Jefferson AA
    Curr Opin Pediatr; 2024 Jun; 36(3):304-309. PubMed ID: 38411592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.